Contact this trialFirst, we need to learn more about you.
Alkylating agents
PCI-24781 + Temozolomide for Recurrent Brain Cancer
Recruiting1 awardPhase 1
Omaha, Nebraska
This trial aims to find a better treatment for glioma, a type of brain cancer. It studies the effects of combining PCI-24781 and metronomic temozolomide to see if it can help those whose cancer has returned.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service